Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Snap Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.38 (market cap $4.03B), while Snap Inc trades at $6.07 (market cap $10.32B). The key difference: Snap Inc is far larger — about 2.6× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Snap Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Snap Inc for 68 Days on average.
| INDV | SNAP | |
|---|---|---|
Market Cap | $4.03B | $10.32B |
Volume | 2,781,171 | 47,200,145 |
Sector | Health | Media |
52-Week High | $41.83 | $9.09 |
52-Week Low | $24.09 | $3.93 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $4.32B | $11.88B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SNAP trades at $6.49, down 0.76% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $7.91. Revenue growth is improving, with 2025 revenue at $5.93B and net losses narrowing to -$460M. Recent news highlights AI and AR developments, including partnerships with NVIDIA and Salesforce for its SPECS glasses, driving positive sentiment.
The outlook is cautiously optimistic as SNAP shows operational progress with narrowing losses and strategic moves into AI/AR. Key risks include persistent unprofitability, high debt, and competitive pressures. Upside potential exists if monetization of new initiatives accelerates, but investors should weigh execution risks against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
